Rhenman & Partners Asset Management Ab West Pharmaceutical Services Inc Transaction History

Rhenman & Partners Asset Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$354.9 - $412.41 $60.7 Million - $70.5 Million	-171,000 Reduced 95.0%	9,000 $3.38 Million
Q3 2023 Nov 09, 2023	BUY	$354.9 - $412.41 $60.7 Million - $70.5 Million	171,000 Added 1900.0%	180,000 $67.5 Million
Q2 2023 Aug 11, 2023	SELL	$334.63 - $382.47 $2.01 Million - $2.29 Million	-6,000 Reduced 40.0%	9,000 $3.44 Million
Q1 2023 May 11, 2023	SELL	$232.5 - $346.47 $2.33 Million - $3.46 Million	-10,000 Reduced 40.0%	15,000 $5.2 Million
Q4 2022 Feb 13, 2023	BUY	$209.34 - $261.61 $1.67 Million - $2.09 Million	8,000 Added 47.06%	25,000 $5.88 Million
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $4.18 Million - $5.84 Million	17,000 New	17,000 $3.91 Million

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.5B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.